107 related articles for article (PubMed ID: 3158761)
1. [Cell surface markers of childhood leukemias and lymphomas].
Shibuya A; Shinozawa T; Yoshikawa T; Katayama I
Rinsho Ketsueki; 1985 Jan; 26(1):7-14. PubMed ID: 3158761
[No Abstract] [Full Text] [Related]
2. [Heterogeneity of surface characteristics of lymphoid cells altered by malignancy].
Batinić D; Boranić M
Lijec Vjesn; 1985 Jul; 107(7):273-7. PubMed ID: 3160902
[No Abstract] [Full Text] [Related]
3. Definition of the high-risk acute lymphoblastic leukemia patient by immunological phenotyping with monoclonal antibodies.
Zipf TF; Fox RI; Dilley J; Levy R
Cancer Res; 1981 Nov; 41(11 Pt 2):4786-9. PubMed ID: 6975160
[TBL] [Abstract][Full Text] [Related]
4. [Distribution of leukemia-associated antigens (CALLA, P24 antigen and P20 antigen) on childhood acute lymphoblastic leukemia cells and nonhematopoietic tissues].
Ochiai J; Komada Y; Shimizu K; Kamiya H; Sakurai M
Rinsho Ketsueki; 1987 Sep; 28(9):1522-7. PubMed ID: 2963922
[No Abstract] [Full Text] [Related]
5. Phenotypic analysis of childhood acute lymphoblastic leukemia and its clinical implication.
Hung IJ; Yang CP; Su IJ
Taiwan Yi Xue Hui Za Zhi; 1985 Sep; 84(9):1051-8. PubMed ID: 2936865
[No Abstract] [Full Text] [Related]
6. Reactivity of Leu 1 and T101 monoclonal antibodies with B cell lymphomas (correlations with other immunological markers).
Al Saati T; Laurent G; Caveriviere P; Rigal F; Delsol G
Clin Exp Immunol; 1984 Dec; 58(3):631-8. PubMed ID: 6239721
[TBL] [Abstract][Full Text] [Related]
7. Southwest Oncology Group experience with immunological phenotyping in acute lymphocytic leukemia of childhood.
Pullen DJ; Falletta JM; Crist WM; Vogler LB; Dowell B; Humphrey GB; Blackstock R; Eys JV; Cooper MD; Metzgar RS; Meydrech EF
Cancer Res; 1981 Nov; 41(11 Pt 2):4802-9. PubMed ID: 6975163
[No Abstract] [Full Text] [Related]
8. Multimarker analysis of childhood acute lymphoblastic leukemia (ALL): heterogeneity of cellular phenotypes and clinical relevance of immunological defined ALL subclasses.
Thoene I; Kabisch H
Haematol Blood Transfus; 1983; 28():126-30. PubMed ID: 6574949
[No Abstract] [Full Text] [Related]
9. [Analysis of membrane-associated antigen of human lymphatic neoplasms and its cellular origin using various monoclonal antibodies].
Tobinai K; Hirose M; Yamada H; Minato K; Shimoyama M
Nihon Ketsueki Gakkai Zasshi; 1982 Nov; 45(6):1055-68. PubMed ID: 7158260
[No Abstract] [Full Text] [Related]
10. [Abnormal phenotype of a chronic lymphatic leukemia: presence of T and B markers defined by monoclonal antibodies].
Gómez Morales M; De Andrés MA; Garrido ML; Delgado C; Cabrera A; Garrido F
Sangre (Barc); 1985; 30(3):348-54. PubMed ID: 3929410
[No Abstract] [Full Text] [Related]
11. [Lymphocyte blastogenesis in vitro in leukemias and lymphomas of childhood].
Fabris C; De Sanctis C; Ponzone A
Minerva Pediatr; 1971 Feb; 23(5):194-8. PubMed ID: 5280413
[No Abstract] [Full Text] [Related]
12. [Immunocytological and kinetic characteristics of leukemic cerebrospinal fluid cells in children with neuroleukemia].
Kurmashov VI; Vladimirskaia EB; Grigor'iants LIa
Pediatriia; 1987; (8):14-9. PubMed ID: 2960949
[No Abstract] [Full Text] [Related]
13. [Immunologic and enzymatic markers of acute infantile lymphoblastic leukemias].
González M; Tamagnini G; San Miguel JF; Lopes DT; Mateos G; Caballero MD; Ribeiro L; López Borrasca A
An Esp Pediatr; 1984 Sep; 21(3):222-8. PubMed ID: 6594963
[TBL] [Abstract][Full Text] [Related]
14. [The presence of CALLA (common acute lymphoblastic leukemia antigens) and B-cell differentiation antigens in lymphocytic lymphoma].
Jarczok K; Hołowiecki J; Stańczuk M; Hołowiecka B; Krawczyk-Kuliś M
Pol Tyg Lek; 1984 Sep; 39(36):1197-9. PubMed ID: 6239146
[No Abstract] [Full Text] [Related]
15. Difference between monoclonal antibodies against the common acute leukemia antigen from two different hybridomas.
Canon C; Eichler-Reiss F; Reizenstein P; Mathé G
Anticancer Res; 1983; 3(6):407-8. PubMed ID: 6230985
[TBL] [Abstract][Full Text] [Related]
16. [Flow cytometric analysis of common ALL antigen and DNA content of leukemic marrow blasts in children with ALL].
Tsurusawa M; Katano N; Yamamoto Y; Kawai S; Fujimoto T; Naruse M
Rinsho Ketsueki; 1986 May; 27(5):738-46. PubMed ID: 2943911
[No Abstract] [Full Text] [Related]
17. [Surface marker analysis of lymphoid malignancy].
Takiguchi T; Konda S
Rinsho Byori; 1984 Sep; 32(9):946-53. PubMed ID: 6394824
[No Abstract] [Full Text] [Related]
18. Heterogeneity of non-T, non-B acute lymphocytic leukemia defined by the quantitative expression of Ia and common all antigens.
Okamura J; Letarte M; Gelfand EW
Leuk Res; 1984; 8(3):335-43. PubMed ID: 6235405
[TBL] [Abstract][Full Text] [Related]
19. [Studies on heterogenous expression of cell surface antigens in childhood acute leukemia].
Kawai S; Yamamoto Y; Utsumi J; Koizumi S; Yanai M; Kawakami K; Iwai T; Ariyoshi N; Oka T; Mimaya J
Rinsho Ketsueki; 1988 Dec; 29(12):2264-71. PubMed ID: 3246710
[No Abstract] [Full Text] [Related]
20. Low-grade lymphomas. Expression of developmentally regulated B-cell antigens.
Cossman J; Neckers LM; Hsu S; Longo D; Jaffe ES
Am J Pathol; 1984 Apr; 115(1):117-24. PubMed ID: 6201073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
